HomeOwner SearchCategory Search
Visit USCOPharmaceutical Research [Published: 2017-01-31. Issue: vol. 34, no. 2, February 2017]
Serial Registration
Copyright Title
Pharmaceutical Research [Published: 2017-01-31. Issue: vol. 34, no. 2, February 2017]
Status
Published
on 6 Mar 2017
Year of Creation
2017
Copyright Claimant
Springer Science+Business Media LLC
Registration Number
TX0008394910
on 6 Mar 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008394910) dated 6 Mar 2017, pertains to an electronic file (eService) titled "Pharmaceutical Research [Published: 2017-01-31. Issue: vol. 34, no. 2, February 2017]" created in 2017. The copyright holder is Springer Science+Business Media LLC, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media LLC.
Application Details
Registration Number
TX0008394910
Registration Date
3/6/2017
Year of Creation
2017
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media LLC
First Publication Nation
United States
ISSN
0724-8741
Preexisting Material
artwork, photograph(s), text, previously published online
Notes
Copyright Local Holdings: vol. 34, no. 2, February 2017 Created 2017 Pub. 2017-01-31 Reg. 2017-03-09 TX0008394910 CDAV
Material Matter Claimed Note: compilation
Statements
Application Title Statement: Pharmaceutical Research
Author Statement: Springer Science+Business Media LLC employer for hire Domicile: United States Citizenship: United States Authorship: compilation
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.